Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Characterization of aberrant splicing of von Willebrand factor in von Willebrand disease: an underrecognized mechanism

Lindsey Hawke, Mackenzie L. Bowman, Man-Chiu Poon, Mary-Frances Scully, Georges-Etienne Rivard, Paula D. James

Blood (2016) 128 (4): 584–593.

https://doi.org/10.1182/blood-2015-10-678052

Published: 2016

Includes: Supplemental data

Journal Articles

Long-Term Outcomes Of a Small Cohort At a Single Canadian Centre Of Severe Subunit A FXIII Deficient Patients (F13A1: c.691-1G>A) Treated Prophylactically With Fibrogammin P

Andrew P Sullivan, Jill MacDonald, Charlotte Sheppard, Mary-Frances Scully, MRCP, FRCP

Blood (2013) 122 (21): 2360.

https://doi.org/10.1182/blood.V122.21.2360.2360

Published: 2013

Journal Articles

In Vitro and Ex Vivo Investigation of Aberrant and Alternative Splicing of Von Willebrand Factor.

Lindsey G Hawke, Paula D. James, MD, Mary-Frances Scully, MRCP, FRCP

Blood (2012) 120 (21): 2179.

https://doi.org/10.1182/blood.V120.21.2179.2179

Published: 2012

Journal Articles

Effect of Mild Hemophilia A on Quality of Life Using the SF-36.

Meghan C. Walsh, PhD, David Macgregor, CGC, Brendan Barrett, MD, Susan Stuckless, MSc, Marc Kawaja, MSc, Mary-Frances Scully, MD

Blood (2006) 108 (11): 5537.

https://doi.org/10.1182/blood.V108.11.5537.5537

Published: 2006

Journal Articles

The Clinical Impact of Mild Hemophilia A, Report of a Cohort Study.

Mary-Frances Scully, David MacGregor, Meghan Walsh, Brendan Barrett, Marc Kawaja, Charlotte Sheppard

Blood (2005) 106 (11): 3210.

https://doi.org/10.1182/blood.V106.11.3210.3210

Published: 2005

Journal Articles

Retrospective Audit of a Factor VIII Continuous Infusion Protocol to Examine Inhibitor Formation, Complications and Product Use.

Meghan Walsh, PhD (ABD), Rebecca Mulcahy, BSc, Mary-Frances Scully, MB, BAO, BCh

Blood (2004) 104 (11): 4030.

https://doi.org/10.1182/blood.V104.11.4030.4030

Published: 2004

NARROW

Characterization of aberrant splicing of von Willebrand factor in von Willebrand disease: an underrecognized mechanism

Long-Term Outcomes Of a Small Cohort At a Single Canadian Centre Of Severe Subunit A FXIII Deficient Patients (F13A1: c.691-1G>A) Treated Prophylactically With Fibrogammin P

In Vitro and Ex Vivo Investigation of Aberrant and Alternative Splicing of Von Willebrand Factor.

Effect of Mild Hemophilia A on Quality of Life Using the SF-36.

The Clinical Impact of Mild Hemophilia A, Report of a Cohort Study.

Retrospective Audit of a Factor VIII Continuous Infusion Protocol to Examine Inhibitor Formation, Complications and Product Use.

Email alerts

ASH Publications

American Society of Hematology

Characterization of aberrant splicing of von Willebrand factor in von Willebrand disease: an underrecognized mechanism

Long-Term Outcomes Of a Small Cohort At a Single Canadian Centre Of Severe Subunit A FXIII Deficient Patients (F13A1: c.691-1G>A) Treated Prophylactically With Fibrogammin P

In Vitro and Ex Vivo Investigation of Aberrant and Alternative Splicing of Von Willebrand Factor.

Effect of Mild Hemophilia A on Quality of Life Using the SF-36.

The Clinical Impact of Mild Hemophilia A, Report of a Cohort Study.

Retrospective Audit of a Factor VIII Continuous Infusion Protocol to Examine Inhibitor Formation, Complications and Product Use.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only